Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal and Stem Cell Research

Executive Summary: Y-27632 dihydrochloride is a potent, cell-permeable, and selective inhibitor of Rho-associated protein kinases (ROCK1/2), with an IC50 of ~140 nM for ROCK1 and a Ki of 300 nM for ROCK2, and over 200-fold selectivity versus other kinases (APExBIO product data). It is widely used to study cytoskeletal dynamics, enhance stem cell viability, and suppress tumor invasion in both in vitro and in vivo models (Yu et al. 2023). Y-27632 disrupts Rho-mediated stress fiber formation, modulates cell cycle progression, and inhibits cytokinesis in a concentration- and time-dependent manner. The compound is soluble in DMSO, ethanol, and water at defined concentrations and requires careful handling for storage stability. This article synthesizes peer-reviewed findings and product specifications to guide research applications and avoid common misconceptions.

Biological Rationale

The Rho/ROCK signaling axis is central to cytoskeletal organization, cell migration, and proliferation. ROCK1 and ROCK2 are serine/threonine kinases activated by RhoA-GTP, mediating actin-myosin contractility, cell shape, and junction integrity. Inhibition of these kinases is essential for dissecting mechanisms of cell motility, tumor invasion, and stem cell survival (Yu et al. 2023). Y-27632 dihydrochloride, offered by APExBIO, is a benchmark tool for selective ROCK inhibition with minimal off-target effects on kinases such as PKC, MLCK, and PAK (APExBIO).

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 binds directly to the ATP-binding pocket of ROCK1 and ROCK2, inhibiting their catalytic activity. The compound has an IC50 of approximately 140 nM for ROCK1 and a Ki of 300 nM for ROCK2, which is over 200-fold more selective than for other kinases. This specificity ensures selective blockade of Rho-mediated phosphorylation of downstream targets, including myosin light chain (MLC) and LIM kinase, resulting in the disassembly of actin stress fibers, reduction in focal adhesions, and altered cell morphology. Inhibition of ROCK signaling by Y-27632 also affects cell cycle progression (G1/S transition) and disrupts cytokinesis in dividing cells (Yu et al. 2023; APExBIO).

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 with an IC50 of ~140 nM and ROCK2 with a Ki of 300 nM in biochemical assays (APExBIO).
• Exhibits >200-fold selectivity over kinases such as PKC, cAMP-dependent protein kinase, MLCK, and PAK in kinase panels (APExBIO).
• Reduces prostatic smooth muscle cell proliferation in vitro in a concentration-dependent manner (0.1–10 µM, 24–72 h) (Yu et al. 2023).
• Suppresses tumor invasion and metastasis in mouse models by inhibiting pathological actin structures and cell migration (Yu et al. 2023).
• Enhances stem cell viability and survival during passaging, particularly for human pluripotent stem cells (10 µM, 24–48 h post-dissociation) (Yu et al. 2023).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is used in a variety of research contexts:

• Stem Cell Research: Prevents apoptosis in human and mouse embryonic stem cells during single-cell dissociation, thus facilitating efficient colony formation and maintenance.
• Cytoskeletal Studies: Disrupts actin stress fiber formation, enabling analysis of Rho/ROCK signaling in cell shape and motility (see this comparison; this article provides updated in vivo benchmarks and guidance for storage/solubility not featured in prior reviews).
• Cancer/Tumor Biology: Inhibits tumor cell migration and reduces metastasis by blocking ROCK-mediated cytoskeletal remodeling (related article; here, we clarify quantitative selectivity and solubility parameters for translational workflows).
• Proliferation and Cell Cycle Assays: Modulates cell cycle progression from G1 to S phase and interferes with cytokinesis.

Common Pitfalls or Misconceptions

• Y-27632 is not a general apoptosis inhibitor; its anti-apoptotic effects are context-dependent and primarily observed in stem cell cultures.
• Long-term storage of prepared solutions (>1 month) at room temperature leads to compound degradation; always store aliquots below -20°C for stability (APExBIO).
• Inhibition of kinases beyond ROCK1/2 is negligible at recommended concentrations, but off-target effects may emerge at >50 µM.
• Y-27632 does not reverse established actin-myosin structures in all cell types; some differentiated cells are refractory to ROCK inhibition.
• Solubility must be optimized for each solvent; incomplete dissolution in aqueous buffers may reduce efficacy.

Workflow Integration & Parameters

Y-27632 dihydrochloride (APExBIO A3008) is supplied as a solid and should be stored desiccated at 4°C or below. For solution preparation, dissolve in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), or water (≥52.9 mg/mL). For complete dissolution, warming to 37°C or using an ultrasonic bath is recommended. Stock solutions are stable for several months at -20°C, but repeated freeze-thaw cycles should be avoided. Optimal working concentrations are typically 1–10 µM for cell-based assays. In human pluripotent stem cell cultures, 10 µM Y-27632 is commonly added for 24–48 hours post-dissociation (Yu et al. 2023).

For advanced troubleshooting and comparative protocols, see this detailed protocol guide, which focuses on optimization strategies and expands on the mechanistic discussion presented here.

Conclusion & Outlook

Y-27632 dihydrochloride is a gold-standard, selective ROCK inhibitor enabling precise dissection of Rho/ROCK signaling in cell biology, cancer research, and stem cell engineering. Its documented potency, selectivity, and solubility profile make it a critical research tool, especially for stem cell viability and cytoskeletal studies. Ongoing work explores its utility in organoid culture, tissue engineering, and advanced cancer models. For comprehensive product information and ordering, visit the APExBIO Y-27632 dihydrochloride product page.